Alpha-glucosidase

Results: 67



#Item
1May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to Im

May 27, 2014 BioMarin Doses First Patient in Phase 3 INSPIRE Trial With BMN 701 for the Treatment of Pompe Disease Proprietary Glycosylation Independent Lysosomal Targeting (GILT) Tagging Technology Has Been Shown to Im

Add to Reading List

Source URL: www.apjohnventures.com

Language: English - Date: 2014-05-29 15:30:33
2PRECOSE® is therapeutically desired. Following oral dosing of healthy volunteers with 14C-labeled acarbose, peak plasma concentrations of radioactivity were (acarbose tablets) attained 14–24 hours after dosing, while

PRECOSE® is therapeutically desired. Following oral dosing of healthy volunteers with 14C-labeled acarbose, peak plasma concentrations of radioactivity were (acarbose tablets) attained 14–24 hours after dosing, while

Add to Reading List

Source URL: www.univgraph.com

Language: English - Date: 2011-08-04 09:47:10
3440 PRIMARY CARE DIABETOLOGY Initiating oral anti diabetic drug: alternatives to metformin Sanjay Kalra,1 Yashdeep Gupta2

440 PRIMARY CARE DIABETOLOGY Initiating oral anti diabetic drug: alternatives to metformin Sanjay Kalra,1 Yashdeep Gupta2

Add to Reading List

Source URL: jpma.org.pk

Language: English - Date: 2015-03-29 08:42:26
4alpha-AMYLASE AND GLUCOAMYLASE FROM ASPERGILLUS ORYZAE, VAR.

alpha-AMYLASE AND GLUCOAMYLASE FROM ASPERGILLUS ORYZAE, VAR.

Add to Reading List

Source URL: www.fao.org

Language: English - Date: 2012-07-13 05:17:48
5Indian Journal of Biotechnology Vol 7, January 2008, pp[removed]Evaluation of α- and β-glucosidase inhibitory properties of macro-algae using intestinal extracts of marine snail, Thais rudolphi (Lamarck, 1822) V S Pramit

Indian Journal of Biotechnology Vol 7, January 2008, pp[removed]Evaluation of α- and β-glucosidase inhibitory properties of macro-algae using intestinal extracts of marine snail, Thais rudolphi (Lamarck, 1822) V S Pramit

Add to Reading List

Source URL: nopr.niscair.res.in

Language: English - Date: 2009-01-06 23:30:19
6PRECOSE® is therapeutically desired. Following oral dosing of healthy volunteers with 14C-labeled acarbose, peak plasma concentrations of radioactivity were (acarbose tablets) attained 14–24 hours after dosing, while

PRECOSE® is therapeutically desired. Following oral dosing of healthy volunteers with 14C-labeled acarbose, peak plasma concentrations of radioactivity were (acarbose tablets) attained 14–24 hours after dosing, while

Add to Reading List

Source URL: www.univgraph.com

Language: English - Date: 2011-08-04 09:47:10
7Type 2 Diabetes Medications: Alpha-Glucosidase Inhibitors One class of diabetes medications are the alpha-glucosidase (AL-fa-glooKOH-sih-days) inhibitors. How Do Alpha-Gulcosidase Inhibitors Work? Alpha-glucosidase inhib

Type 2 Diabetes Medications: Alpha-Glucosidase Inhibitors One class of diabetes medications are the alpha-glucosidase (AL-fa-glooKOH-sih-days) inhibitors. How Do Alpha-Gulcosidase Inhibitors Work? Alpha-glucosidase inhib

Add to Reading List

Source URL: urbanext.illinois.edu

Language: English - Date: 2013-12-05 16:48:51
8Type 2 Diabetes Medications: Classes of Medications The class of a medication tells you how a medication works. There are six major classes of oral glucose lowering medications. • Sulfonylureas • Meglitinides

Type 2 Diabetes Medications: Classes of Medications The class of a medication tells you how a medication works. There are six major classes of oral glucose lowering medications. • Sulfonylureas • Meglitinides

Add to Reading List

Source URL: urbanext.illinois.edu

Language: English - Date: 2013-12-05 16:48:51
9Lysosomal Storage Disorder Quarterly Report PROFICIENCY TESTING Volume 3, No. 4

Lysosomal Storage Disorder Quarterly Report PROFICIENCY TESTING Volume 3, No. 4

Add to Reading List

Source URL: www.cdc.gov

Language: English - Date: 2014-11-19 11:17:57
10EVIDENCE REVIEW: POMPE DISEASE Prepared for: THE ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN FINAL V[removed]

EVIDENCE REVIEW: POMPE DISEASE Prepared for: THE ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND CHILDREN FINAL V[removed]

Add to Reading List

Source URL: www.hrsa.gov

Language: English - Date: 2014-12-04 01:12:52